Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals

The metabolism of (poly)phenols and some host metabolites, including bile acids (BAs) and cholesterol, varies among individuals depending on their gut microbiota. The gut microbial metabolism of ellagitannins (ETs) and ellagic acid (EA) produces urolithins (Uros), yielding three metabotypes with qua...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Food & function 2024-03, Vol.15 (5), p.2422-2432
Hauptverfasser: Cortés-Martín, Adrián, Iglesias-Aguirre, Carlos E, Marín, Alicia, Romo-Vaquero, María, Vallejo, Fernando, Espín, Juan Carlos, Victoria Selma, María
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2432
container_issue 5
container_start_page 2422
container_title Food & function
container_volume 15
creator Cortés-Martín, Adrián
Iglesias-Aguirre, Carlos E
Marín, Alicia
Romo-Vaquero, María
Vallejo, Fernando
Espín, Juan Carlos
Victoria Selma, María
description The metabolism of (poly)phenols and some host metabolites, including bile acids (BAs) and cholesterol, varies among individuals depending on their gut microbiota. The gut microbial metabolism of ellagitannins (ETs) and ellagic acid (EA) produces urolithins (Uros), yielding three metabotypes with quantitative and qualitative differences based on dissimilar Uro-producing profiles (UM-A, UM-B, and UM-0, i.e. , non-producers). Previous animal studies demonstrated that polyphenols impact BAs and cholesterol microbial metabolism, but data on their effects in humans and data regarding the inter-individual variability of these metabolic conversions are scant. We evaluated whether UMs, as distinctive functional gut-microbiome signatures, could determine the potential effect of a pomegranate extract (PE) rich in ET-EA on the metabolism of BAs and cholesterol in mild dyslipidaemic overweight-obese individuals, with possible consequences on host-lipid homeostasis and gut health. At the baseline, UM-B presented the highest levels of faecal total and secondary BAs and coprostanol, suggesting that the lipid absorption capacity and gut cytotoxic risk could be augmented in UM-B. PE intake significantly reduced faecal coprostanol and BA production, especially secondary BAs, and modulated the gut microbiome, reducing the gut cytotoxic risk, especially in UM-B individuals. The lowering of faecal microbial coprostanol and BAs and some BA-metabolising bacteria was quantitatively correlated with Uro concentrations, mainly faecal Uro-A. This suggests that PE consumption could exert cardiovascular and gut protection through Uro-A production as a direct driver of the effects and indirectly by reducing the Coriobacteriaceae family and BA pool, known factors involved in the gut absorption of lipids. Urolithin-A drives the effects of pomegranate on the microbial metabolism of bile acids and cholesterol with possible consequences on human health.
doi_str_mv 10.1039/d3fo05014a
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_38329279</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2934361525</sourcerecordid><originalsourceid>FETCH-LOGICAL-c296t-719d3a55f867dbe4c0b70b3440fb56b5113dec9a92b82818214e570201de83813</originalsourceid><addsrcrecordid>eNpdkk1rVDEUhoMottRu3CsBNyKM5vPeZDlUq0KhGwvuLvk4dyYl92ZMckf6o_yPZjptBbM5gfPkPYf3DUKvKflICdefPB8TkYQK8wydMiLYqpPk5_PHu9DdCTov5Za0w7VWWr1EJ1xxplmvT9Gfm5xiqNsw4zXe5eQXV0Oasc9hDwXXLWAYR3C14DTiXZpgk81sKuAGHbqbpeIpuJxsMBFPUI1tgmU64DZEwMYFX7CZPXbbFKFUaBNxmzeF6LG_KzHsgjfQRHDaQ_4NYbOt9w-ShQIN9WEf_GJieYVejK3A-UM9QzeXX35cfFtdXX_9frG-Wjmmu7rqqfbcSDmqrvcWhCO2J5YLQUYrOysp5R6cNppZxRRVjAqQPWGEelBcUX6G3h91myO_lrbzMIXiIEYzQ1rK0MzjmhKlRUPf_YfepiXPbbtGccE7Kpls1Icj1YwqJcM47HKYTL4bKBkOOQ6f-eX1fY7rBr99kFzsBP4JfUytAW-OQC7uqfvvI_C_b9KkYA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2934361525</pqid></control><display><type>article</type><title>Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals</title><source>MEDLINE</source><source>Royal Society Of Chemistry Journals 2008-</source><creator>Cortés-Martín, Adrián ; Iglesias-Aguirre, Carlos E ; Marín, Alicia ; Romo-Vaquero, María ; Vallejo, Fernando ; Espín, Juan Carlos ; Victoria Selma, María</creator><creatorcontrib>Cortés-Martín, Adrián ; Iglesias-Aguirre, Carlos E ; Marín, Alicia ; Romo-Vaquero, María ; Vallejo, Fernando ; Espín, Juan Carlos ; Victoria Selma, María</creatorcontrib><description>The metabolism of (poly)phenols and some host metabolites, including bile acids (BAs) and cholesterol, varies among individuals depending on their gut microbiota. The gut microbial metabolism of ellagitannins (ETs) and ellagic acid (EA) produces urolithins (Uros), yielding three metabotypes with quantitative and qualitative differences based on dissimilar Uro-producing profiles (UM-A, UM-B, and UM-0, i.e. , non-producers). Previous animal studies demonstrated that polyphenols impact BAs and cholesterol microbial metabolism, but data on their effects in humans and data regarding the inter-individual variability of these metabolic conversions are scant. We evaluated whether UMs, as distinctive functional gut-microbiome signatures, could determine the potential effect of a pomegranate extract (PE) rich in ET-EA on the metabolism of BAs and cholesterol in mild dyslipidaemic overweight-obese individuals, with possible consequences on host-lipid homeostasis and gut health. At the baseline, UM-B presented the highest levels of faecal total and secondary BAs and coprostanol, suggesting that the lipid absorption capacity and gut cytotoxic risk could be augmented in UM-B. PE intake significantly reduced faecal coprostanol and BA production, especially secondary BAs, and modulated the gut microbiome, reducing the gut cytotoxic risk, especially in UM-B individuals. The lowering of faecal microbial coprostanol and BAs and some BA-metabolising bacteria was quantitatively correlated with Uro concentrations, mainly faecal Uro-A. This suggests that PE consumption could exert cardiovascular and gut protection through Uro-A production as a direct driver of the effects and indirectly by reducing the Coriobacteriaceae family and BA pool, known factors involved in the gut absorption of lipids. Urolithin-A drives the effects of pomegranate on the microbial metabolism of bile acids and cholesterol with possible consequences on human health.</description><identifier>ISSN: 2042-6496</identifier><identifier>EISSN: 2042-650X</identifier><identifier>DOI: 10.1039/d3fo05014a</identifier><identifier>PMID: 38329279</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Absorption ; Animals ; Bile acids ; Bile Acids and Salts ; Body weight ; Cholestanol ; Cholesterol ; Coumarins ; Cytotoxicity ; Ellagic acid ; Gastrointestinal Microbiome ; Homeostasis ; Humans ; Intestinal microflora ; Lipid metabolism ; Lipids ; Metabolism ; Metabolites ; Microbiomes ; Microbiota ; Microorganisms ; Obesity - drug therapy ; Obesity - metabolism ; Overweight ; Overweight - metabolism ; Phenols ; Polyphenols ; Pomegranate</subject><ispartof>Food &amp; function, 2024-03, Vol.15 (5), p.2422-2432</ispartof><rights>Copyright Royal Society of Chemistry 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c296t-719d3a55f867dbe4c0b70b3440fb56b5113dec9a92b82818214e570201de83813</cites><orcidid>0000-0001-7164-7934 ; 0000-0001-5542-4984 ; 0000-0002-6780-974X ; 0000-0002-0084-6060 ; 0000-0002-1068-8692</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38329279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cortés-Martín, Adrián</creatorcontrib><creatorcontrib>Iglesias-Aguirre, Carlos E</creatorcontrib><creatorcontrib>Marín, Alicia</creatorcontrib><creatorcontrib>Romo-Vaquero, María</creatorcontrib><creatorcontrib>Vallejo, Fernando</creatorcontrib><creatorcontrib>Espín, Juan Carlos</creatorcontrib><creatorcontrib>Victoria Selma, María</creatorcontrib><title>Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals</title><title>Food &amp; function</title><addtitle>Food Funct</addtitle><description>The metabolism of (poly)phenols and some host metabolites, including bile acids (BAs) and cholesterol, varies among individuals depending on their gut microbiota. The gut microbial metabolism of ellagitannins (ETs) and ellagic acid (EA) produces urolithins (Uros), yielding three metabotypes with quantitative and qualitative differences based on dissimilar Uro-producing profiles (UM-A, UM-B, and UM-0, i.e. , non-producers). Previous animal studies demonstrated that polyphenols impact BAs and cholesterol microbial metabolism, but data on their effects in humans and data regarding the inter-individual variability of these metabolic conversions are scant. We evaluated whether UMs, as distinctive functional gut-microbiome signatures, could determine the potential effect of a pomegranate extract (PE) rich in ET-EA on the metabolism of BAs and cholesterol in mild dyslipidaemic overweight-obese individuals, with possible consequences on host-lipid homeostasis and gut health. At the baseline, UM-B presented the highest levels of faecal total and secondary BAs and coprostanol, suggesting that the lipid absorption capacity and gut cytotoxic risk could be augmented in UM-B. PE intake significantly reduced faecal coprostanol and BA production, especially secondary BAs, and modulated the gut microbiome, reducing the gut cytotoxic risk, especially in UM-B individuals. The lowering of faecal microbial coprostanol and BAs and some BA-metabolising bacteria was quantitatively correlated with Uro concentrations, mainly faecal Uro-A. This suggests that PE consumption could exert cardiovascular and gut protection through Uro-A production as a direct driver of the effects and indirectly by reducing the Coriobacteriaceae family and BA pool, known factors involved in the gut absorption of lipids. Urolithin-A drives the effects of pomegranate on the microbial metabolism of bile acids and cholesterol with possible consequences on human health.</description><subject>Absorption</subject><subject>Animals</subject><subject>Bile acids</subject><subject>Bile Acids and Salts</subject><subject>Body weight</subject><subject>Cholestanol</subject><subject>Cholesterol</subject><subject>Coumarins</subject><subject>Cytotoxicity</subject><subject>Ellagic acid</subject><subject>Gastrointestinal Microbiome</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Intestinal microflora</subject><subject>Lipid metabolism</subject><subject>Lipids</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Microbiomes</subject><subject>Microbiota</subject><subject>Microorganisms</subject><subject>Obesity - drug therapy</subject><subject>Obesity - metabolism</subject><subject>Overweight</subject><subject>Overweight - metabolism</subject><subject>Phenols</subject><subject>Polyphenols</subject><subject>Pomegranate</subject><issn>2042-6496</issn><issn>2042-650X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkk1rVDEUhoMottRu3CsBNyKM5vPeZDlUq0KhGwvuLvk4dyYl92ZMckf6o_yPZjptBbM5gfPkPYf3DUKvKflICdefPB8TkYQK8wydMiLYqpPk5_PHu9DdCTov5Za0w7VWWr1EJ1xxplmvT9Gfm5xiqNsw4zXe5eQXV0Oasc9hDwXXLWAYR3C14DTiXZpgk81sKuAGHbqbpeIpuJxsMBFPUI1tgmU64DZEwMYFX7CZPXbbFKFUaBNxmzeF6LG_KzHsgjfQRHDaQ_4NYbOt9w-ShQIN9WEf_GJieYVejK3A-UM9QzeXX35cfFtdXX_9frG-Wjmmu7rqqfbcSDmqrvcWhCO2J5YLQUYrOysp5R6cNppZxRRVjAqQPWGEelBcUX6G3h91myO_lrbzMIXiIEYzQ1rK0MzjmhKlRUPf_YfepiXPbbtGccE7Kpls1Icj1YwqJcM47HKYTL4bKBkOOQ6f-eX1fY7rBr99kFzsBP4JfUytAW-OQC7uqfvvI_C_b9KkYA</recordid><startdate>20240304</startdate><enddate>20240304</enddate><creator>Cortés-Martín, Adrián</creator><creator>Iglesias-Aguirre, Carlos E</creator><creator>Marín, Alicia</creator><creator>Romo-Vaquero, María</creator><creator>Vallejo, Fernando</creator><creator>Espín, Juan Carlos</creator><creator>Victoria Selma, María</creator><general>Royal Society of Chemistry</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7T7</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7164-7934</orcidid><orcidid>https://orcid.org/0000-0001-5542-4984</orcidid><orcidid>https://orcid.org/0000-0002-6780-974X</orcidid><orcidid>https://orcid.org/0000-0002-0084-6060</orcidid><orcidid>https://orcid.org/0000-0002-1068-8692</orcidid></search><sort><creationdate>20240304</creationdate><title>Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals</title><author>Cortés-Martín, Adrián ; Iglesias-Aguirre, Carlos E ; Marín, Alicia ; Romo-Vaquero, María ; Vallejo, Fernando ; Espín, Juan Carlos ; Victoria Selma, María</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c296t-719d3a55f867dbe4c0b70b3440fb56b5113dec9a92b82818214e570201de83813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Absorption</topic><topic>Animals</topic><topic>Bile acids</topic><topic>Bile Acids and Salts</topic><topic>Body weight</topic><topic>Cholestanol</topic><topic>Cholesterol</topic><topic>Coumarins</topic><topic>Cytotoxicity</topic><topic>Ellagic acid</topic><topic>Gastrointestinal Microbiome</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Intestinal microflora</topic><topic>Lipid metabolism</topic><topic>Lipids</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Microbiomes</topic><topic>Microbiota</topic><topic>Microorganisms</topic><topic>Obesity - drug therapy</topic><topic>Obesity - metabolism</topic><topic>Overweight</topic><topic>Overweight - metabolism</topic><topic>Phenols</topic><topic>Polyphenols</topic><topic>Pomegranate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cortés-Martín, Adrián</creatorcontrib><creatorcontrib>Iglesias-Aguirre, Carlos E</creatorcontrib><creatorcontrib>Marín, Alicia</creatorcontrib><creatorcontrib>Romo-Vaquero, María</creatorcontrib><creatorcontrib>Vallejo, Fernando</creatorcontrib><creatorcontrib>Espín, Juan Carlos</creatorcontrib><creatorcontrib>Victoria Selma, María</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Food &amp; function</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cortés-Martín, Adrián</au><au>Iglesias-Aguirre, Carlos E</au><au>Marín, Alicia</au><au>Romo-Vaquero, María</au><au>Vallejo, Fernando</au><au>Espín, Juan Carlos</au><au>Victoria Selma, María</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals</atitle><jtitle>Food &amp; function</jtitle><addtitle>Food Funct</addtitle><date>2024-03-04</date><risdate>2024</risdate><volume>15</volume><issue>5</issue><spage>2422</spage><epage>2432</epage><pages>2422-2432</pages><issn>2042-6496</issn><eissn>2042-650X</eissn><abstract>The metabolism of (poly)phenols and some host metabolites, including bile acids (BAs) and cholesterol, varies among individuals depending on their gut microbiota. The gut microbial metabolism of ellagitannins (ETs) and ellagic acid (EA) produces urolithins (Uros), yielding three metabotypes with quantitative and qualitative differences based on dissimilar Uro-producing profiles (UM-A, UM-B, and UM-0, i.e. , non-producers). Previous animal studies demonstrated that polyphenols impact BAs and cholesterol microbial metabolism, but data on their effects in humans and data regarding the inter-individual variability of these metabolic conversions are scant. We evaluated whether UMs, as distinctive functional gut-microbiome signatures, could determine the potential effect of a pomegranate extract (PE) rich in ET-EA on the metabolism of BAs and cholesterol in mild dyslipidaemic overweight-obese individuals, with possible consequences on host-lipid homeostasis and gut health. At the baseline, UM-B presented the highest levels of faecal total and secondary BAs and coprostanol, suggesting that the lipid absorption capacity and gut cytotoxic risk could be augmented in UM-B. PE intake significantly reduced faecal coprostanol and BA production, especially secondary BAs, and modulated the gut microbiome, reducing the gut cytotoxic risk, especially in UM-B individuals. The lowering of faecal microbial coprostanol and BAs and some BA-metabolising bacteria was quantitatively correlated with Uro concentrations, mainly faecal Uro-A. This suggests that PE consumption could exert cardiovascular and gut protection through Uro-A production as a direct driver of the effects and indirectly by reducing the Coriobacteriaceae family and BA pool, known factors involved in the gut absorption of lipids. Urolithin-A drives the effects of pomegranate on the microbial metabolism of bile acids and cholesterol with possible consequences on human health.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>38329279</pmid><doi>10.1039/d3fo05014a</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7164-7934</orcidid><orcidid>https://orcid.org/0000-0001-5542-4984</orcidid><orcidid>https://orcid.org/0000-0002-6780-974X</orcidid><orcidid>https://orcid.org/0000-0002-0084-6060</orcidid><orcidid>https://orcid.org/0000-0002-1068-8692</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2042-6496
ispartof Food & function, 2024-03, Vol.15 (5), p.2422-2432
issn 2042-6496
2042-650X
language eng
recordid cdi_pubmed_primary_38329279
source MEDLINE; Royal Society Of Chemistry Journals 2008-
subjects Absorption
Animals
Bile acids
Bile Acids and Salts
Body weight
Cholestanol
Cholesterol
Coumarins
Cytotoxicity
Ellagic acid
Gastrointestinal Microbiome
Homeostasis
Humans
Intestinal microflora
Lipid metabolism
Lipids
Metabolism
Metabolites
Microbiomes
Microbiota
Microorganisms
Obesity - drug therapy
Obesity - metabolism
Overweight
Overweight - metabolism
Phenols
Polyphenols
Pomegranate
title Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T15%3A28%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Urolithin%20A%20production%20drives%20the%20effects%20of%20pomegranate%20on%20the%20gut%20microbial%20metabolism%20of%20bile%20acids%20and%20cholesterol%20in%20mild%20dyslipidaemic%20overweight%20and%20obese%20individuals&rft.jtitle=Food%20&%20function&rft.au=Cort%C3%A9s-Mart%C3%ADn,%20Adri%C3%A1n&rft.date=2024-03-04&rft.volume=15&rft.issue=5&rft.spage=2422&rft.epage=2432&rft.pages=2422-2432&rft.issn=2042-6496&rft.eissn=2042-650X&rft_id=info:doi/10.1039/d3fo05014a&rft_dat=%3Cproquest_pubme%3E2934361525%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2934361525&rft_id=info:pmid/38329279&rfr_iscdi=true